Fernández-Avilés F - Search Results

1

Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.

Marco DN, Salas MQ, Gutiérrez-García G, Monge I, Riu G, Carcelero E, Roma JR, Llobet N, Arcarons J, Suárez-Lledó M, Martínez N, Pedraza A, Domenech A, Rosiñol L, Fernández-Avilés F, Urbano-Ispízua Á, Rovira M, Brunet M, Martínez C. Marco DN, et al. Pharmaceuticals (Basel). 2022 Dec 9;15(12):1529. doi: 10.3390/ph15121529. Pharmaceuticals (Basel). 2022. PMID: 36558980 Free PMC article.

2

Allogenic stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: experience from a single institution.

Martínez C, Carreras E, Rovira M, Urbano-Ispizua A, Esteve J, Fernández-Avilés F, Perales M, Rives S, Gómez M, Montserrat E. Martínez C, et al. Leuk Res. 2001 May;25(5):379-84. doi: 10.1016/s0145-2126(00)00146-6. Leuk Res. 2001. PMID: 11301105 Clinical Trial.

3

Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?

Urbano-Ispizua A, Carreras E, Marín P, Rovira M, Martínez C, Fernández-Avilés F, Xicoy B, Hernández-Boluda JC, Montserrat E. Urbano-Ispizua A, et al. Blood. 2001 Oct 15;98(8):2352-7. doi: 10.1182/blood.v98.8.2352. Blood. 2001. PMID: 11588030 Free article.

4

Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation.

Gómez M, Urbano-Ispizua A, Cervantes F, Fernández-Avilés F, Rovira M, Carreras E. Gómez M, et al. Haematologica. 2002 Sep;87(9):1003-5. Haematologica. 2002. PMID: 12217814

5

Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood.

Fernández-Avilés F, Urbano-Ispizua A, Aymerich M, Colomer D, Rovira M, Martínez C, Nadal E, Talarn C, Carreras E, Montserrat E. Fernández-Avilés F, et al. Leukemia. 2003 Mar;17(3):613-20. doi: 10.1038/sj.leu.2402854. Leukemia. 2003. PMID: 12646952

6

CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients.

Carreras E, Saiz A, Marín P, Martínez C, Rovira M, Villamor N, Aymerich M, Lozano M, Fernández-Avilés F, Urbano-Izpizua A, Montserrat E, Graus F. Carreras E, et al. Haematologica. 2003 Mar;88(3):306-14. Haematologica. 2003. PMID: 12651270 Clinical Trial.

7

Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.

Fernández-Avilés F, Urbano-Ispizua A, Aymerich M, Rovira M, Martínez C, Talarn C, Jiménez M, Carreras E, Montserrat E. Fernández-Avilés F, et al. Exp Hematol. 2003 Oct;31(10):934-40. doi: 10.1016/s0301-472x(03)00236-4. Exp Hematol. 2003. PMID: 14550809

8

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission.

Nadal E, Giné E, Bladé J, Esteve J, Rosiñol L, Fernández-Avilés F, Marin P, Martinez C, Rovira M, Urbano-Ispizua A, Carreras E, Montserrat E. Nadal E, et al. Bone Marrow Transplant. 2004 Jan;33(1):61-4. doi: 10.1038/sj.bmt.1704313. Bone Marrow Transplant. 2004. PMID: 14704657 Clinical Trial.

9

Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study.

Rovira M, Jimenéz M, De La Bellacasa JP, Mensa J, Rafel M, Ortega M, Almela M, Martínez C, Fernández-Avilés F, Martínez JA, Urbano-Ispizua A, Carreras E, Montserrat E. Rovira M, et al. Transplantation. 2004 Apr 27;77(8):1260-4. doi: 10.1097/01.tp.0000120536.20045.aa. Transplantation. 2004. PMID: 15114095

10

Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.

Jiménez M, Martínez C, Ercilla G, Carreras E, Urbano-Ispízua A, Aymerich M, Villamor N, Amézaga N, Rovira M, Fernández-Avilés F, Gaya A, Martino R, Sierra J, Montserrat E. Jiménez M, et al. Exp Hematol. 2005 Oct;33(10):1240-8. doi: 10.1016/j.exphem.2005.06.016. Exp Hematol. 2005. PMID: 16219547 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

632 results

Search Page

Filters